Empagliflozin/Metformin Tablet 12.5/500 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.
MFDS item code 202302636 · Approved 2023.09.05
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used as an adjunct to diet and exercise to help control blood sugar in adult patients with type 2 diabetes who are appropriate for the combined use of empagliflozin and metformin. It is particularly effective for those adult patients with type 2 diabetes who have inadequate blood sugar control and can also be applied to patients with cardiovascular disease. However, caution is needed with the occurrence of cardiovascular events, referring to clinical trial information from specialists. This medication effectively controls blood sugar to support diabetes management.
The recommended dose is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of the individual components: empagliflozin 25 mg and metformin 2000 mg. For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose 10 mg) and the patient's current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). Patients switching from combination therapy with empagliflozin (total daily dose 10 mg or 25 mg) and metformin to this medicine should receive their current doses of empagliflozin and metformin. When this medicine is used concomitantly with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Drug Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with renal impairment No dose adjustment is necessary in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who do not have other conditions that may increase the risk of lactic acidosis. Since the starting dose of metformin in these patients is 500 mg or 850 mg once daily, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication may cause serious side effects, such as severe lactic acidosis, and patients must notify their physician immediately if symptoms occur. Additionally, it may increase the risk of hypoglycemia if used with insulin or sulfonylureas, so caution is advised. It should not be used in patients with moderate to severe renal impairment or certain acute illnesses. Treatment should be discontinued for a period before and after surgery or radiographic contrast tests, and can only be resumed after renal function has normalized. Women who are pregnant or breastfeeding should not take this medication. This medication may increase the risk of urinary tract infections and genital infections, so immediate treatment is necessary if infection symptoms occur. Patients with signs of fluid volume loss or dehydration must exercise caution when taking this medication, and especially the elderly should regularly monitor their renal function. Regular blood tests are recommended as vitamin B12 deficiency can occur. Alcohol consumption may increase the risk of lactic acidosis, so it should be avoided. Because there is a risk of hypoglycemia, meals should be taken regularly, and dosage adjustments may be necessary when used with other hypoglycemic agents. Caution is advised when driving or operating machinery while taking this medication, and any unusual symptoms should be reported to a physician immediately. This medication is not recommended for children, and dosage adjustments and monitoring of renal function are important for the elderly. In cases of overdose, immediate medical attention is required, and dialysis may be beneficial. This medication should be stored in its original container and kept out of reach of children.
Hypoglycemia, urinary tract infection, genital infection, increased urination, ketoacidosis, lactic acidosis, decreased vitamin B12 absorption, decreased fluid volume, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, abnormal liver function tests, hepatitis, altered taste, itching, rash, urticaria, erythema, angioedema, dysuria, interstitial nephritis, thirst, increased serum lipids, increased serum creatinine, decreased glomerular filtration rate, vulvovaginitis, balanitits, perineal necrosis, fluid volume loss, increased serum creatinine, decreased glomerular filtration rate, gastrointestinal symptoms (diarrhea, nausea, vomiting), decreased serum vitamin B12 concentration, ketoacidosis, urosepsis, pyelonephritis, rash, urticaria, angioedema, perineal necrosis, chronic gastritis, cerebral infarction, soft tissue infection, pneumonia, ankle fracture, lateral epicondylitis, facial bone fracture, musculoskeletal pain, myocardial infarction, pancreatic carcinoma, constipation, gastritis, oral discomfort, salivary gland pain, headache, sensory loss, orthostatic dizziness, dizziness, asthenia, chest discomfort, chest pain, fever, vascular stent stenosis, vascular stent thrombosis, increased alanine aminotransferase, increased aspartate aminotransferase, ureterolithiasis, acute kidney injury, cervical inflammation, hypercholesterolemia, dyslipidemia, vitamin D deficiency, vulvar pruritus, benign prostatic hyperplasia, diabetic foot, low back pain, glaucoma, pathologic myopia, retinal detachment, retinal vein occlusion, traction retinal detachment, epistaxis, asthma, exertional dyspnea, wet cough, allergic rhinitis, residual phlegm, limb injury, road traffic accident, splenic injury, sternum fracture, angina, Prinzmetal angina, coronary artery disease, deep vein thrombosis, insomnia, anxiety, depression, sleep disorder, acute cholecystitis, autoimmune hepatitis, cholelithiasis, hepatitis, otalgia, orthostatic vertigo, vertigo, anemia, lymphadenopathy, hypothyroidism, thyroid nodule, decreased appetite, obesity, diabetes, hyperlipidemia, hyponatremia, dermoid cyst, seborrheic dermatitis, atopic dermatitis, contact dermatitis, heat rash, sebaceous gland hyperplasia, lumbar spinal canal stenosis, myalgia, limb pain, musculoskeletal chest pain, arthralgia, cervical stenosis, fibromyalgia, flank pain, fracture pain, muscle weakness, osteoarthritis, osteoporosis, rotator cuff syndrome, astigmatism, cataract, allergic conjunctivitis, blurred vision, corneal erosion, macular fibrosis, eye discomfort, conjunctival hyperemia, eyelid swelling, visual impairment, vitreous floaters, vitreous hemorrhage, epistaxis, allergic rhinitis, cough, dyspnea, angina, unstable angina, hypertension, weight loss, vulvar pruritus, genital itching
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it should be kept in a location that avoids extremes of temperature, ideally at room temperature between 1 and 30 degrees Celsius.
Biconvex oval film-coated tablet, purple with a light brown tint
Bottle packaging - 60 tablets/bottle, PTP packaging - 60 tablets/box [(10 tablets/PTP X 6)], PTP packaging - 10 tablets/box [(10 tablets/PTP X 1)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Aju Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.